Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,450.00
(
-2.19%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
6.18%
)
Bitcoin
65,998.00
(
-4.05%
)
News Focus
News Focus
Post# of 257298
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122816
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 177092

Monday, 04/21/2014 9:40:47 PM

Monday, April 21, 2014 9:40:47 PM

Post# of 257298

ENTA—PIs have had a history of toxicity so why not get them both in the clinic.

I expect ABT-493 will supersede ABT-450 before ABBV starts a pivotal trial in GT3, provided that the ABT-493 + ABT-530 combination reveals no problems.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today